Sun Pharma Advanced Research Wins Rs 27.51 Crore CENVAT Credit Refund Dispute, Tribunal Dismisses Revenue's Appeal:

Sun Pharma Advanced Research Company secures a favourable tribunal ruling for refund of accumulated CENVAT credit worth Rs 27.51 crore along with applicable interest.
Tribunal Holds in Company's Favour

Sun Pharma Advanced Research Company Limited has informed the stock exchanges about the development concerning its business. The company has disclosed that the tribunal, in a recent hearing, has ruled in its favour by sustaining an Order-in-Appeal dated April 27, 2018.
The tribunal has ruled that the company is entitled to a refund of accumulated CENVAT credit along with consequential interest, where applicable, for an amount of Rs 2751 Lakhs. Accordingly, the final decision has been announced in the company's favour, and the Tax Department's appeal has been dismissed.
The company further clarified that as the final decision has been announced in its favour, it does not expect any impact on its financial position.
The aforementioned disclosure has been made by Sun Pharma Advanced Research Company Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, vide an Intimation dated October 04, 2026, addressed to the National Stock Exchange of India Limited (NSE) and Bombay Stock Exchange Limited (BSE).
Refer to the official intimation for complete information.
About Author

Saloni Kumari
Content Writer
StudyCafe
Delhi, Delhi, India
3047My Recent Articles
- Rane Holdings Subsidiary Gets Relief as GST Authorities Withdraw Rs 11.88 Crore Demand
- MCA Reminds Companies of November 29 Deadline to File PAS-6 for September 2026 Half-Year
- ITAT Restricts Bogus Purchase Disallowance to 1%, Slashes Addition from Rs 50.95 Lakh to Rs 50,950
- ITAT Deletes Rs 53.76 Lakh Addition, Holds Additional Compensation for Compulsory Acquisition of Agricultural Land Tax-Exempt
- Madras HC Upholds Mahindra Holidays’ Revenue Deferral Methodology, Cuts Contingent Liability by Rs 106 Crore
Loading suggestions…
Recent Posts
All Posts
Recent Posts
All Posts










